Rafael Holdings RFL
NYSE RFL
$2.02 +0.00 (+0.00%)
As of: Sep 29, 2026 · 3:58 PM EDT

Rafael Holdings (RFL) Restructuring Costs (2021 - 2022)

Updated

Rafael Holdings (RFL) recorded Restructuring Costs of -$188,000 in fiscal Q2 2022 (quarter ended Jan 31, 2022), compared with $7 million a year earlier.

Analysis

Rafael Holdings (RFL) Restructuring Costs (2021 - 2022) Analysis & Trends

For FY2021 (ended Jul 31, 2021), Rafael Holdings reported Restructuring Costs of $7 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Rafael Holdings 102.93 Mn 108.34 Mn 163,000.00
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2022 -188,000.00
Oct 31, 2021 10.28 Mn
Jan 31, 2021 7.00 Mn
API Access

Rafael Holdings Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=RFL&period=max&api_key=YOUR_API_KEY